cbdMD (YCBD) Asset Utilization Ratio (2017 - 2025)

cbdMD (YCBD) reported Asset Utilization Ratio of 1.72 for Q4 2025, down 3.22% on a YoY basis from 1.78 in Q4 2024, and down 8.96% sequentially from 1.89 in Q3 2025.

cbdMD (YCBD) Asset Utilization Ratio (2017 - 2025) Analysis & Trends

cbdMD (YCBD) has 9 years of Asset Utilization Ratio data on file, last reported at 1.72 in Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio fell 3.22% year-over-year to 1.72; the trailing twelve-month figure through Dec 2025 stood at 1.72 (down 3.22% YoY), and the FY2025 full-year result was 1.83, up 22.82% from the prior year.
  • Asset Utilization Ratio declined to 1.72 in Q4 2025, from 1.89 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.89 in Q3 2025 to a low of 0.39 in Q4 2021.
  • A 5-year average of 1.09 and a median of 0.92 in 2022 frame the typical range for Asset Utilization Ratio.
  • Across the five-year window, Asset Utilization Ratio surged 126.4% in 2022 and declined 3.22% in 2025, its largest moves.
  • Tracing YCBD's Asset Utilization Ratio over 5 years: stood at 0.39 in 2021, then surged by 126.4% to 0.89 in 2022, then soared by 62.37% to 1.44 in 2023, then advanced by 23.02% to 1.78 in 2024, then fell by 3.22% to 1.72 in 2025.
  • Business Quant data shows YCBD's Asset Utilization Ratio at 1.72 in Q4 2025, 1.89 in Q3 2025, and 1.87 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 0.43
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 0.62
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 0.46
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 0.43
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 0.39
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 0.65
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 0.37
10 cbdMD 438,678.80 -2.95 Mn 3.00 Mn 1.72

Historic Data

Download Data
DateValue
Dec 31, 2025 1.72
Sep 30, 2025 1.89
Jun 30, 2025 1.87
Mar 31, 2025 1.78
Dec 31, 2024 1.78
Sep 30, 2024 1.63
Jun 30, 2024 1.39
Mar 31, 2024 1.40
Dec 31, 2023 1.44
Sep 30, 2023 0.95
Jun 30, 2023 0.85
Mar 31, 2023 0.88
Dec 31, 2022 0.89
Sep 30, 2022 0.77
Jun 30, 2022 0.51
Mar 31, 2022 0.43
Dec 31, 2021 0.39
Sep 30, 2021 0.39
Jun 30, 2021 0.42
Mar 31, 2021 0.40